Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Appointed director
|
|
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 6.3% stake in Iovance Biotherapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.2% stake in Iovance Biotherapeutics Inc. |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/24/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 6.5% stake in Iovance Biotherapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 2.9% stake in IOVANCE BIOTHERAPEUTICS, INC. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 5.5% stake in Iovance Biotherapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 7.8% stake in Iovance Biotherapeutics Inc. |
| 02/04/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 6.3% stake in Iovance Biotherapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 5.1% stake in Iovance Biotherapeutics, Inc. |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/24/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 7.5% stake in Iovance Biotherapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 7.6% stake in IOVANCE BIOTHERAPEUTICS INC |
| 02/04/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| venBio Select Advisor LLC reports a 8.9% stake in Iovance Biotherapeutics, Inc. |
| 02/13/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 4.8% stake in Iovance Biotherapeutics, Inc. |
| 02/12/2019 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 3.4% stake in Iovance Biotherapeutics, Inc. |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/28/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 4.3% stake in Iovance Biotherapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 4.5% stake in Iovance Biotherapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| FMR LLC reports a 2.5% stake in IOVANCE BIOTHERAPEUTICS INC |
| 02/12/2018 |
SC 13G/A
| venBio Select Advisor LLC reports a 7.2% stake in Iovance Biotherapeutics, Inc. |
| 02/07/2018 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 6.9% stake in IOVANCE BIOTHERAPEUTICS, INC. |
| 08/02/2017 |
SC 13G/A
| ACUTA CAPITAL PARTNERS, LLC reports a 6.4% stake in IOVANCE BIOTHERAPEUTICS, INC. |
| 05/09/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2017 |
SC 13G/A
| Lion Biotechnologies, Inc. reports a 6.1% stake in LION BIOTECHNOLOGIES, INC. |
| 02/14/2017 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 5.7% stake in Lion Biotechnologies, Inc. |
|
|
|